Overview
Dr. DeVore is a cardiologist and Associate Professor of Medicine in the Department of Medicine, Division of Cardiology, at Duke University School of Medicine. His clinical interests include caring for patients and families with heart failure, including those with left ventricular assist devices and heart transplants. He is involved in and leads multiple large studies of patients with heart failure at both Duke University Medical Center and the Duke Clinical Research Institute. He currently serves as the medical director of the Duke Heart Transplant program.
He attended medical school at the University of Chicago Pritzker School of Medicine and completed internal medicine residency at Brigham and Women’s Hospital. He then pursued cardiology training at Duke University and solidified his interests in clinical research and heart failure. He completed a research fellowship at the Duke Clinical Research Institute and a Masters of Health Sciences in Clinical Research before completing an advanced heart failure fellowship at Duke University.
The overarching goals of his research are to advance the current understanding of heart failure through clinical trials as well as develop an evidence base for implementation strategies that addresses the gap between heart failure trial results and clinical practice. For example, he has served on the Steering Committees for large clinical trials, including PIONEER-HF and SPIRRIT-HFpEF. Dr. DeVore also published the first clinical trial conducted within the American Heart Association’s Get With The Guidelines-Heart Failure program, a registry-based cluster randomized trial of quality improvement interventions. He was also the principal investigator for CONNECT-HF, a large-scale, pragmatic, cluster-randomized trial at 161 sites in the US evaluating heart failure quality improvement initiatives. Outside of his work on heart failure, Dr. DeVore is married with 4 children and spends his time corralling them all and coaching youth baseball.
Current Appointments & Affiliations
Recent Publications
Remote digital intervention targeting heart failure medical therapy: a randomized controlled trial.
Journal Article Lancet Reg Health Am · June 2026 BACKGROUND: Heart failure (HF) causes substantial morbidity and mortality, in part because evidence-based pharmacotherapies remain underused. Remote, asynchronous digital platforms may accelerate the initiation and titration of pharmacotherapies outside of ... Full text Link to item CiteOutcomes among patients bridged to heart transplant with microaxial flow versus durable left ventricular assist device support.
Journal Article J Thorac Cardiovasc Surg · May 2026 OBJECTIVE: To evaluate characteristics and outcomes of patients bridged to orthotopic heart transplantation with microaxial left ventricular assist device (ma-LVAD) versus durable LVAD (d-LVAD). METHODS: This was a single-center retrospective cohort study ... Full text Link to item CiteBetween Withdrawal and Death: Can Machine Learning Improve DCD Utilization?
Journal Article The Journal of Heart and Lung Transplantation · May 2026 Full text CiteRecent Grants
Heart Transplantation Research Network
ResearchPrincipal Investigator · Awarded by American Heart Association · 2026 - 2030A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO ASSESS EFFICACY AND SAFETY OF OMECAMTIV MECARBIL IN PATIENTS WITH SYMPTOMATIC HEART FAILURE WITH SEVERELY REDUCED EJECTION FRACTION
Clinical TrialPrincipal Investigator · Awarded by Cytokinetics, Inc. · 2025 - 20291/2 Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction Extension Trial
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2028View All Grants